In Table 9, the scores of patients are lower than thoseof controls, suggesting that LC severely affected patients’quality of life. With SOD as the exception, scores weresignificantly different, as seen in Table 10, and longerclinical courses were associated with lower scores. Perhapsbecause LC is the final stage of liver disease progression,by the time patients have received a definite diagnosis,they may already have lost the ability to engage in socialactivity; therefore scores in this domain did not differ. Ofcourse, measurement error cannot be excluded as an explanation, but it had little effect on discriminant validity.In summary, the LC-PROM was well able to differentiatehealth and LC patients in varying clinical courses